Correlation Between Talis Biomedical and Neuropace
Can any of the company-specific risk be diversified away by investing in both Talis Biomedical and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talis Biomedical and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talis Biomedical Corp and Neuropace, you can compare the effects of market volatilities on Talis Biomedical and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talis Biomedical with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talis Biomedical and Neuropace.
Diversification Opportunities for Talis Biomedical and Neuropace
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Talis and Neuropace is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Talis Biomedical Corp and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Talis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talis Biomedical Corp are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Talis Biomedical i.e., Talis Biomedical and Neuropace go up and down completely randomly.
Pair Corralation between Talis Biomedical and Neuropace
If you would invest 637.00 in Neuropace on November 2, 2024 and sell it today you would earn a total of 782.00 from holding Neuropace or generate 122.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 1.67% |
| Values | Daily Returns |
Talis Biomedical Corp vs. Neuropace
Performance |
| Timeline |
| Talis Biomedical Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Neuropace |
Talis Biomedical and Neuropace Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Talis Biomedical and Neuropace
The main advantage of trading using opposite Talis Biomedical and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talis Biomedical position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.| Talis Biomedical vs. Tivic Health Systems | Talis Biomedical vs. Bluejay Diagnostics | Talis Biomedical vs. Heart Test Laboratories | Talis Biomedical vs. Nuwellis |
| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |